The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.

Detalles Bibliográficos
Autores principales: Zhou, Haiyan, Muntoni, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Letter to the Editor ‐ Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567137/
https://www.ncbi.nlm.nih.gov/pubmed/32705767
http://dx.doi.org/10.1002/jcsm.12608
_version_ 1783596262148276224
author Zhou, Haiyan
Muntoni, Francesco
author_facet Zhou, Haiyan
Muntoni, Francesco
author_sort Zhou, Haiyan
collection PubMed
description
format Online
Article
Text
id pubmed-7567137
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75671372020-10-21 The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al. Zhou, Haiyan Muntoni, Francesco J Cachexia Sarcopenia Muscle Letter to the Editor ‐ Reply John Wiley and Sons Inc. 2020-07-23 2020-10 /pmc/articles/PMC7567137/ /pubmed/32705767 http://dx.doi.org/10.1002/jcsm.12608 Text en © 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor ‐ Reply
Zhou, Haiyan
Muntoni, Francesco
The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
title The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
title_full The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
title_fullStr The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
title_full_unstemmed The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
title_short The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
title_sort authors reply: letter on: "myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by zhou et al.
topic Letter to the Editor ‐ Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567137/
https://www.ncbi.nlm.nih.gov/pubmed/32705767
http://dx.doi.org/10.1002/jcsm.12608
work_keys_str_mv AT zhouhaiyan theauthorsreplyletteronmyostatininhibitionincombinationwithantisenseoligonucleotidetherapyimprovesoutcomesinspinalmuscularatrophybyzhouetal
AT muntonifrancesco theauthorsreplyletteronmyostatininhibitionincombinationwithantisenseoligonucleotidetherapyimprovesoutcomesinspinalmuscularatrophybyzhouetal
AT zhouhaiyan authorsreplyletteronmyostatininhibitionincombinationwithantisenseoligonucleotidetherapyimprovesoutcomesinspinalmuscularatrophybyzhouetal
AT muntonifrancesco authorsreplyletteronmyostatininhibitionincombinationwithantisenseoligonucleotidetherapyimprovesoutcomesinspinalmuscularatrophybyzhouetal

Ejemplares similares